Christopher D'Angelo studies a wide range of health issues, with a primary focus on blood cancers such as chronic lymphocytic leukemia (CLL) and multiple myeloma (MM). He is also involved in researching rare tumors, like pseudomyogenic hemangioendothelioma, and exploring how the gut microbiome might affect cancer progression. Additionally, his work looks at novel treatments, including BCL2 inhibitors and CAR T-cell therapy, which can lead to better outcomes for patients who have not responded to standard therapies. Beyond cancer, D'Angelo also investigates the impact of environmental factors on health, such as how microplastics affect coral reefs.
Key findings
In a review of chronic lymphocytic leukemia treatment options, BCL2 inhibitors led to a significantly higher rate of undetectable measurable residual disease compared to traditional therapies.
In multiple myeloma patients with central nervous system involvement, about 90% showed nerve-related problems, but advanced immunotherapy methods like CAR T-cell therapy showed promise for management.
In an intervention study for urban Latino middle school children with asthma, participants in the ASMAS program experienced improved asthma control, better sleep, and reduced school absences.
Older patients on anticoagulant therapy undergoing percutaneous coronary interventions had a 38% rate of negative health outcomes within a year, higher than the 21% in younger patients.
Research on the gut microbiome in CLL mice showed that targeting harmful bacteria delayed disease onset, highlighting a potential new strategy for CLL management.
Frequently asked questions
Does Dr. D'Angelo study cancer?
Yes, he focuses primarily on blood cancers like chronic lymphocytic leukemia and multiple myeloma.
What treatments has Dr. D'Angelo researched?
He has researched innovative treatments such as BCL2 inhibitors and CAR T-cell therapy.
Is Dr. D'Angelo's work relevant to patients with asthma?
Yes, his research includes interventions aimed at improving asthma management for children, particularly in urban Latino populations.
How does Dr. D'Angelo's research benefit elderly patients?
His studies identify risks associated with anticoagulant therapy in elderly patients undergoing heart procedures, helping healthcare providers manage their care.
What does Dr. D'Angelo study about environmental impacts?
He investigates how microplastics affect coral health, which has implications for marine ecosystems.
Publications in plain English
Development and tailoring of a peer-administered asthma management intervention for urban Latino middle school children.
2026
The Journal of asthma : official journal of the Association for the Care of Asthma
Koinis-Mitchell D, D'Angelo C, Coutinho MT, Kopel SJ, Noga R +8 more
Plain English This study focused on improving asthma management for Latino middle school children in urban areas, where they often face difficulties like stress and limited access to medications. Researchers developed a program called ASMAS, which included four sessions led by peers, and tested it with 81 students. The results showed that those who participated in ASMAS had better asthma control, slept better, missed fewer days of school, felt more confident in managing their asthma, and had better access to necessary asthma treatments.
Who this helps: This benefits children with asthma, particularly those from Latino backgrounds living in urban settings.
Plain English This study looked at how microplastics are absorbed by corals, which are crucial to marine ecosystems. Researchers used a special advanced imaging technique to see microplastic beads within coral skeletons, finding that these beads were mostly present in corals that were unhealthy and losing tissue. Specifically, they discovered that corals with signs of bleaching absorbed more microplastics compared to healthy ones, which is concerning because it shows that deteriorating coral conditions make them more vulnerable to plastic pollution.
Who this helps: This information benefits marine biologists, environmental scientists, and conservationists working to protect coral reefs.
Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology.
2026
Journal of the National Comprehensive Cancer Network : JNCCN
Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M +32 more
Plain English This study focuses on how to best treat multiple myeloma (MM), a type of blood cancer, using updated guidelines from the National Comprehensive Cancer Network (NCCN). The guidelines emphasize that treatment should be personalized, considering each patient's specific situation. These recommendations help doctors make better decisions for both newly diagnosed patients and those with recurring or resistant cases of MM.
Who this helps: Patients with multiple myeloma and their doctors.
Diagnosis and Management of Multiple Myeloma With Central Nervous System Involvement.
2026
Journal of the National Comprehensive Cancer Network : JNCCN
D'Angelo CR, Derman BA, Devarakonda S, Godara A, Lee HC +3 more
Plain English This study looked at a serious type of multiple myeloma (MM) that affects the central nervous system (CNS), which can lead to severe symptoms like headaches, confusion, and seizures. About 90% of patients showed nerve-related problems on MRIs. New treatments, especially advanced immunotherapy methods like CAR T-cell therapy, are showing promise for better managing these cases, offering hope where there was once little.
Who this helps: This benefits patients with multiple myeloma that has spread to the brain or spinal cord.
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.
2026
Journal of the National Comprehensive Cancer Network : JNCCN
Wierda WG, Brown J, Abramson JS, Awan F, Bociek G +32 more
Plain English This research discusses new treatment options for patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). It found that using a specific type of treatment called BCL2 inhibitors led to better outcomes, such as higher rates of having no detectable cancer (known as undetectable measurable residual disease) compared to traditional therapies. Notably, two newer treatments, pirtobrutinib and a type of CAR T-cell therapy, provide hope for patients whose disease has not improved with earlier treatments.
Who this helps: This research helps patients with CLL/SLL, especially those with difficult-to-treat forms of the disease.
Pseudomyogenic Hemangioendothelioma With Novel NEDD9::FOSB Fusion Gene.
2026
Pediatric dermatology
Sampath S, D'Angelo C, Shenoy A, Rubrecht A, Aldrink JH +1 more
Plain English Researchers studied a rare skin tumor called pseudomyogenic hemangioendothelioma (PMHE) in an 18-year-old male patient who had a painful, raised brown area on his thigh for two years. They found a new gene fusion, NEDD9::FOSB, which could help improve diagnosis and treatment options for this condition. This discovery is important because understanding the genetic makeup of PMHE may lead to better-targeted therapies in the future.
Who this helps: This helps patients with pseudomyogenic hemangioendothelioma and their doctors.
Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS Data.
2025
Transplantation and cellular therapy
Ellithi M, Elsallab M, Lunning MA, Holstein SA, Sharma S +5 more
Plain English This research studied the safety of two CAR T cell therapies, cilta-cel and ide-cel, used to treat patients with blood cancers. Out of over 4.4 million adverse event reports, 1,496 were linked to these treatments. It found that common problems included nerve issues and infections, with cilta-cel showing a high risk for Guillain-Barre syndrome and ide-cel linked to serious heart issues. Understanding these side effects is important for ensuring patient safety.
Who this helps: This helps patients receiving CAR T therapies and their doctors.
Development of a method for detecting and classifying hydrocarbon-contaminated soils via laser-induced breakdown spectroscopy and machine learning algorithms.
2025
Environmental science and pollution research international
Martino LJ, Einschlag FSG, D'Angelo CA
Plain English This study focused on creating a new method to detect and classify soils contaminated with oil and other hydrocarbons. Researchers used a technique called laser-induced breakdown spectroscopy (LIBS) combined with machine learning, which achieved over 90% accuracy in identifying different types of contamination, and even reached 100% accuracy for specific groups like gasoline and different oils. This is important because it helps improve how we monitor and manage polluted sites, ultimately protecting the environment and public health.
Who this helps: Patients, communities living near contaminated sites, and environmental regulators.
Effect of Dzyaloshinskii Moriya interaction on magnetic tunnel junction based molecular spintronics devices (MTJMSD).
2025
Scientific reports
Sankhi BR, D'Angelo C, Thompson D, Tyagi P
Plain English This study looked at how a specific interaction, called the Dzyaloshinskii-Moriya interaction (DMI), affects magnetic tunnel junctions used in molecular spintronics devices. Researchers found that the presence of DMI significantly reduced the magnetization of the ferromagnetic electrode, which can explain why some experiments showed a loss of magnetic contrast in these devices. Understanding this interaction is important because it can help improve the performance of these devices, which could lead to advancements in technology such as more efficient data storage and processing.
Who this helps: This benefits researchers and engineers developing new electronic devices that use molecular spintronics.
Mantle cell lymphoma: from pathogenesis to treatment for 2024 and beyond.
2025
Panminerva medica
O'Leary AM, D'Angelo CR
Plain English This paper examines mantle cell lymphoma (MCL), a rare type of blood cancer, and the different ways it can be treated based on its subtypes. Researchers found that treatment varies widely, from watchful waiting to chemotherapy and newer targeted therapies, with survivorship improving as novel treatments like BTK inhibitors and CAR-T therapy become more common. Understanding how to best manage MCL, especially in cases with specific genetic mutations and complicated symptoms, is essential for providing effective care.
Who this helps: This information benefits patients with mantle cell lymphoma and their doctors.
CLO25-054: Long Term Follow Up of Patients Undergoing High Dose Chemotherapy and Autologous or Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma.
2025
Journal of the National Comprehensive Cancer Network : JNCCN
Frimpong SA, Shostrom V, Bociek RG, Lunning M, D'Angelo C +2 more
TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.
2025
Cell death & disease
Petti E, Di Vito S, Dinami R, Porru M, Marchesi S +19 more
Plain English This study looked at how a protein called TRF2 affects the behavior of triple negative breast cancer cells. Researchers found that TRF2 helps these cells move and spread by interacting with components of the cell's nuclear envelope, which is essential for cell organization and migration. In human breast cancers, higher levels of TRF2 were linked to faster cancer progression and worse outcomes, making it a potential target for new treatments.
Who this helps: This research benefits patients with triple negative breast cancer by identifying a new target for therapy.
Ensuring Sustainability in Pharmaceutical Care: A Retrospective Analysis of Administrative Databases on the Utilization, Costs, and Switching Patterns of Biological Therapies in the Agency for Health Protection of the Metropolitan Area of Milan.
2025
Pharmaceuticals (Basel, Switzerland)
Langfelder RMB, Langella R, D'Angelo C, Panico C, Cattaneo S
Plain English This study looked at the use and costs of biosimilars—cheaper versions of biological drugs—over three years in a large healthcare organization in Milan, which serves over 3.5 million people. It found that from 2022 to 2024, the use of biosimilars increased significantly, leading to potential savings of over €36 million, which could help improve healthcare services and access to treatments. However, some drugs did not see as much adoption, indicating that there are still challenges to address.
Who this helps: Patients and the healthcare system.
The Elevation and Impact of Peripheral Bile Acids in Chronic Lymphocytic Leukemia.
2025
Biomedicines
Smith AL, Ridout A, Skupa SA, Martinez-Rico R, Drengler EM +3 more
Plain English This study investigated the levels of bile acids in the blood of patients with chronic lymphocytic leukemia (CLL) and found that these levels were higher in CLL patients compared to healthy individuals. Specifically, the researchers noted that while bile acids were present in greater amounts in those with CLL, they did not significantly affect the growth of CLL cells or the function of T-cells related to the disease. Understanding these bile acids may help researchers find new ways to treat or manage CLL better.
Who this helps: This helps patients with chronic lymphocytic leukemia.
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
2025
Journal of the National Comprehensive Cancer Network : JNCCN
Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M +30 more
Plain English This study reviews the latest guidelines on how to diagnose and treat multiple myeloma, a type of blood cancer. It highlights new recommendations for both new patients and those who have already been treated, ensuring that they receive the best possible care. These updates are crucial because they help improve treatment outcomes and quality of life for patients.
Who this helps: Patients with multiple myeloma and their healthcare teams.
Urinary metabolites as biomarkers of dietary intake: a systematic review.
2025
Frontiers in nutrition
Jackson MK, Wang B, Rasmussen H, Natarajan SK, Bilek LD +6 more
Plain English This study looked at how urine tests can be used to better understand what people eat. Researchers examined 65 studies and found specific substances in urine that can accurately indicate dietary intake for broad food categories like fruits, vegetables, and grains, but they struggled to identify individual foods. This is important because improving how we track diets can lead to better health research and help manage chronic diseases.
Who this helps: This benefits patients and doctors by providing more accurate dietary assessments.
Transversal Competencies in Operating Room Nurses: A Hierarchical Task Analysis.
2025
Nursing reports (Pavia, Italy)
Reato F, Ivziku D, Lommi M, Bresil A, Andreotti A +4 more
Plain English This study focused on the skills that operating room nurses need to keep patients safe during surgeries. Researchers found that these nurses require 15 key competencies, including teamwork, communication, problem-solving, and stress management, along with 153 specific tasks they perform in their roles. These findings highlight the importance of updating nursing education to include these essential skills, not just technical training, to improve both patient safety and nurse effectiveness.
Who this helps: This helps nursing students, practicing nurses, and ultimately, patients undergoing surgery.
Gut Microbiome Profiling in Eμ-TCL1 Mice Reveals Intestinal Changes and a Dysbiotic Signature Specific to Chronic Lymphocytic Leukemia.
2025
Cancer research communications
Skupa SA, Cooper KM, Smith AL, Drengler EM, Eiken AP +8 more
Plain English This study examined how the gut microbiome changes in mice with chronic lymphocytic leukemia (CLL). Researchers found that mice with leukemia had more harmful bacteria and markers indicating damage to the intestinal barrier. When these mice were treated with antibiotics to remove their gut bacteria, they showed delayed disease onset and more effective immune responses, suggesting that the microbiome might influence CLL progression.
Who this helps: This helps patients with chronic lymphocytic leukemia by highlighting the potential role of gut health in their disease management.
Changes in host gene expression patterns underpin responses of the coral Stylophora pistillata to nutrient stress.
2025
Scientific reports
Page TM, D'Angelo C, Wiedenmann J, Foster GL
Plain English This study looked at how the coral Stylophora pistillata reacts to different levels of dissolved nutrients, specifically nitrogen and phosphorus, over eight weeks. The researchers found that while the overall growth and calcification of the corals didn't change much, those in low phosphorus conditions bleached and had fewer symbiotic algae. These low nutrient levels triggered specific changes in the coral's gene activity that help it deal with nutrient shortages.
Who this helps: This helps coral reef researchers and conservationists understand how to better protect coral health in changing environments.
Clinical characteristics, therapeutic strategies, and outcomes in elderly patients on oral anticoagulant therapy undergoing percutaneous coronary interventions:analysis of the PERSEO Registry.
2025
Journal of geriatric cardiology : JGC
Minardi S, De Rosa S, Salvi N, Andò G, Talanas G +7 more
Plain English This study analyzed the health outcomes of older patients (80 years and above) who were on blood-thinning medications and underwent a procedure called percutaneous coronary intervention (PCI) to open blocked arteries, comparing them to younger patients. Among the 1,234 patients studied, those aged 80 and older had a 38% rate of negative health events within a year, compared to 21% for younger patients, and they also faced higher rates of major bleeding (9% vs. 6%). These findings highlight the increased risks for older patients on anticoagulants, suggesting a need for careful management in this vulnerable group.
Who this helps: This helps elderly patients and their healthcare providers by identifying risks associated with their treatment.
Ultra-low-field MRI: a David versus Goliath challenge in modern imaging.
2025
La Radiologia medica
Gagliardo C, Feraco P, Contrino E, D'Angelo C, Geraci L +5 more
Plain English This study looked at ultra-low-field MRI (ULF-MRI), which uses lower magnetic fields than typical MRI machines to create images of the body. Researchers found that recent improvements in technology now make ULF-MRI capable of producing better quality images while being safer for patients with metal implants and more portable for use in various settings. This is important because it could make MRI scans more accessible to people who need them, especially in places where traditional high-field machines are not practical.
Who this helps: This benefits patients who need imaging but have limitations or restrictions due to traditional MRI machines.
Novel Insights Into the Struggle Against Biofilm: The PsyOmp38 Protein From the Antarctic Marine Bacterium Psychrobacter sp. TAE2020.
2025
Microbial biotechnology
Olimpo D, D'Angelo C, Imbimbo P, Morelli M, Tutino ML +4 more
Plain English This research studied a protein called PsyOmp38 from an Antarctic bacterium, which can help fight against harmful biofilms created by bacteria like Staphylococcus epidermidis. The researchers found that PsyOmp38 can stop bacteria from sticking to surfaces and can break down existing biofilms, making antibiotics like vancomycin work better by reducing the needed concentration for effectiveness. This discovery is important because it offers a potential new way to treat infections that are difficult to manage due to biofilms.
Who this helps: Patients with hard-to-treat infections and doctors looking for better treatment options.
Multi-omics analyses integration reveals a novel TRF2-miR-181a-5p-S100A10 regulatory axis in colon cancer.
2025
Cellular & molecular biology letters
Dinami R, Petti E, Ostano P, Iachettini S, Rizzo A +14 more
Plain English This study explored the role of a protein called TRF2 in colon cancer and its influence on gene expression. Researchers found that TRF2 affects the activity of 717 genes related to cancer, and specifically identifies a pathway where TRF2 interacts with another protein to regulate a molecule called miR-181a-5p, which targets a protein associated with cancer growth called S100A10. This discovery helps to clarify how TRF2 contributes to cancer development beyond its traditional role in protecting chromosome ends, which could lead to new treatments for colon cancer.
Who this helps: This benefits patients with colon cancer and their doctors.
Capsular polysaccharide from Psychrobacter sp. TAE2020: An unusual amino sugar-enriched macromolecule with anti-biofilm and emulsification activities.
2025
Carbohydrate polymers
D'Amico R, Casillo A, Olimpo D, Gallucci N, D'Angelo C +4 more
Plain English This study looked at a substance called CATASAN produced by a marine bacterium, Psychrobacter sp. TAE2020, which has the ability to prevent biofilm formation—a major issue in infections. Researchers found that the key component of CATASAN is a polysaccharide with a specific structure made up of four sugar units. This polysaccharide may offer a new way to fight infections and could also be used in products that mix oil and water.
Who this helps: This benefits patients dealing with infections, particularly those affected by biofilms.
Modulating TERRA G-quadruplexes with ligands: impact on telomeric DNA:RNA hybrids and ALT mechanisms.
2025
Nucleic acids research
Dinoi F, Marzano S, Marino MI, Vertecchi E, D'Angelo CM +9 more
Plain English This study examined how certain FDA-approved drugs can affect a type of RNA called TERRA, which plays a crucial role in maintaining telomeres—protective caps on the ends of chromosomes. The researchers discovered that these drugs help TERRA bind more effectively to telomeres, which in turn increases the formation of DNA:RNA hybrids and leads to defects at the telomeres in cancer cells. Notably, they found that this interaction can promote mechanisms of alternative lengthening of telomeres (ALT), which is a way that some cancer cells grow and survive.
Who this helps: This research helps patients with cancers that utilize ALT for telomere maintenance.
The Role of Artificial Intelligence in Palliative Oncology: Zeroing in on Hematologic Malignancies.
2025
Oncology (Williston Park, N.Y.)
Thirugnanasambandam RP, Bauer A, D'Angelo C
Plain English This study looked at how artificial intelligence (AI) is being used in palliative oncology, especially for blood cancers like leukemia and lymphoma. Researchers found that AI can help doctors manage symptoms better, predict patient outcomes more accurately, and personalize care by analyzing health data. This matters because it can lead to improved quality of life for patients and better treatment strategies.
Who this helps: This helps patients with blood cancers and their healthcare providers.
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
2024
Journal of the National Comprehensive Cancer Network : JNCCN
Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M +31 more
Plain English This study outlines updated treatment guidelines for Waldenström macroglobulinemia and lymphoplasmacytic lymphoma, focusing on new treatment options available for patients. The guidelines help doctors make informed decisions about diagnosing and treating this type of cancer, ensuring that patients receive the most effective care possible. This is important because having clear and updated guidelines can lead to better outcomes for patients dealing with these conditions.
Who this helps: Patients with Waldenström macroglobulinemia and lymphoplasmacytic lymphoma, as well as their doctors.
Calvanese M, D'Angelo C, Lauro C, Tutino ML, Parrilli E
Plain English Researchers studied how to use a type of bacteria from the Antarctic, called TAC125, grown in a biofilm (a group of bacteria that stick together) to produce two fluorescent proteins: GFP and mScarlet. They found that while this biofilm method takes longer than traditional methods, it can produce proteins with better quality and requires fewer resources, like less sugar and no antibiotics. This is important because it opens up new ways to produce complex proteins that could be useful for various biotechnological applications.
Who this helps: This helps scientists and companies working on protein-based products, including potential treatments and therapies.
EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders.
2024
Orphanet journal of rare diseases
Atalaia A, Wandrei D, Lalout N, Thompson R, Tassoni A +33 more
Plain English The EURO-NMD Registry is a collection of data from patients with neuromuscular disorders seen at specialized centers across Europe. This registry is designed to gather important medical information, including clinical details and genetic data, to help facilitate research and improve treatment for these rare conditions. By connecting with other patient registries, it allows for better data sharing and collaboration, ultimately aiming to enhance healthcare for neuromuscular disease patients.
Who this helps: This helps patients with neuromuscular disorders and the doctors treating them.
Cold-Azurin, a New Antibiofilm Protein Produced by the Antarctic Marine Bacteriumsp. TAE6080.
2024
Marine drugs
D'Angelo C, Trecca M, Carpentieri A, Artini M, Selan L +3 more
Plain English Researchers studied a protein called cold-azurin, produced by a type of Antarctic bacterium, to see if it could prevent biofilm formation, which is known to cause infections linked to medical devices. They found that cold-azurin stops bacteria from sticking to surfaces and forming harmful biofilms, showing a strong ability to prevent these formations. This is important because biofilms can lead to serious infections and complications in patients with medical devices.
Who this helps: This helps patients with medical devices, like catheters and implants, by reducing the risk of infections.
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.
2024
Journal of experimental & clinical cancer research : CR
Iachettini S, Terrenato I, Porru M, Di Vito S, Rizzo A +19 more
Plain English This study focused on a protein called TRF2 and its role in helping triple negative breast cancer (TNBC) respond better to taxane-based therapies, which are commonly used to treat this aggressive cancer. The researchers found that higher levels of TRF2 made TNBC cells more sensitive to these treatments, leading to better tumor reduction and lower chances of recurrence after surgery. Specifically, their findings suggest that TRF2 could be used as a marker to predict how well TNBC patients will respond to this type of chemotherapy.
Who this helps: This helps patients with triple negative breast cancer.
Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System.
2024
Blood
Elsallab M, Ellithi M, Lunning MA, D'Angelo C, Ma J +3 more
Plain English This study looked at the occurrence of new cancers in patients who received CAR T-cell therapy, a type of cancer treatment. Out of over 12,000 reports of side effects, 536 cases (about 4.3%) involved patients developing new cancers, especially types affecting white blood cells. This finding is important because it highlights a potential risk of getting additional cancers after this therapy, which needs more investigation.
Who this helps: This helps patients and doctors by informing them about possible risks of CAR T-cell therapy.
Eiken AP, Smith AL, Skupa SA, Schmitz E, Rana S +13 more
Plain English Researchers investigated a new treatment called SpiD3 for chronic lymphocytic leukemia (CLL), particularly in cases where traditional treatments like ibrutinib have failed. They found that SpiD3 effectively targets key survival pathways in CLL cells, reducing tumor growth in lab studies and in mice. This is significant because it shows promise for treating resistant forms of CLL, potentially improving outcomes for patients who have not responded to existing therapies.
Who this helps: Patients with chronic lymphocytic leukemia, especially those resistant to current treatments.
BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia.
2024
JCI insight
Smith AL, Skupa SA, Eiken AP, Reznicek TE, Schmitz E +14 more
Plain English This study looked at how blocking a specific protein, known as BET, can improve the immune responses of T cells in patients with chronic lymphocytic leukemia (CLL). Researchers found that using a BET inhibitor, called OPN-51107, led to a significant reduction in signs of T cell exhaustion, allowing these immune cells to grow better and function more effectively; specifically, there was a noticeable decrease in inhibitory molecules on T cells, which are markers of exhaustion. This finding is important because it suggests that BET inhibitors could help restore the ability of T cells to fight cancer in CLL patients.
Who this helps: This benefits patients with chronic lymphocytic leukemia.
I Am Afraid I Will Not Be Able to Walk, That Is What Worries Me-The Experience of Patients with Knee Osteoarthritis before Total Knee Arthroplasty: A Qualitative Study.
2024
Journal of clinical medicine
Longo UG, Corradini A, Marchetti A, Di Sarno C, D'Angelo C +4 more
Plain English This study looked at the experiences of nine patients with knee osteoarthritis who were waiting for knee replacement surgery. Researchers found that patients are often worried about pain affecting their daily activities, have fears about their condition getting worse, and struggle with severe pain at night that affects their sleep. Understanding these concerns is important because it can lead to better support and education for patients before their surgery, helping them recover more effectively afterwards.
Who this helps: This helps patients preparing for knee replacement surgery.
The scientific standing of nations and its relationship with economic competitiveness.
2024
PloS one
Abramo G, D'Angelo CA
Plain English This study looked at how the quality of scientific research in different countries affects their economic competitiveness and development. It compared countries in the OECD and eight others, finding that nations with strong research performance are more competitive economically. The research showed a clear link: countries that invest more in research also perform better in scientific output, which is important for their growth and prosperity.
Who this helps: This helps policymakers and national leaders aiming to improve their countries' economic performance through better investment in research.
Giant thigh hemosiderotic/aneurysmal dermatofibroma: Case report with radiologic-pathologic correlation.
2024
Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia
Pena-Burgos EM, D'Angelo C, Díez-Corral MC, Sánchez Villanueva E, Tapia-Viñe M +2 more
Plain English Researchers studied a rare type of skin tumor called hemosiderotic/aneurysmal dermatofibroma in a 53-year-old woman who had a large tumor on her thigh measuring 7.6 cm. They used imaging and a biopsy to identify the tumor, confirming it was not cancerous even though it could be mistaken for malignant cancers. The patient had the tumor surgically removed and did not experience any recurrence or spread of the disease afterward.
Who this helps: This information is useful for doctors diagnosing similar skin tumors in patients.
Whole-Cell Biosensor for Iron Monitoring as a Potential Tool for Safeguarding Biodiversity in Polar Marine Environments.
2024
Marine drugs
Calvanese M, D'Angelo C, Tutino ML, Lauro C
Plain English This research looks at how to monitor iron levels in polar marine environments using whole-cell biosensors made from marine microorganisms. High or low iron concentrations can harm marine life and biodiversity, so the study found that these biosensors could give real-time, cost-effective measurements. This is important because it can help scientists manage and protect fragile marine ecosystems more effectively.
Who this helps: This benefits environmental scientists and conservationists working to protect marine biodiversity.
Exosomal TNF-α mediates voltage-gated Na+ channel 1.6 overexpression and contributes to brain tumor-induced neuronal hyperexcitability.
2024
The Journal of clinical investigation
Sanchez Trivino CA, Spelat R, Spada F, D'Angelo C, Manini I +8 more
Plain English This study looked at how brain tumors, specifically gliomas, cause increased electrical activity in neurons, which can lead to seizures. Researchers found that substances called exosomes released by glioma cells contain a protein called TNF-α that triggers this heightened neuron activity. In tests, when neurons were exposed to TNF-α, their electrical activity increased dramatically, and a specific channel in the neurons linked to this hyperactivity was overexpressed. Importantly, a drug called infliximab, used for rheumatoid arthritis, significantly reduced this unwanted electrical activity.
Who this helps: This research benefits glioma patients experiencing epilepsy.
UP150 Project: A Longitudinal Analysis of Active Lifestyles in the Complex Working System.
2024
Sports (Basel, Switzerland)
Signorini G, Scurati R, Bosio A, D'Angelo C, Benedini S +4 more
Plain English This study looked at the UP150 office design, which encourages employees to be more active at work, aiming to reduce health issues from sitting too much. Over a year, 48 desk workers were divided into two groups: one used the UP150 features and the other did not. Workers using UP150 saw improvements like increased physical activity and better mental well-being, along with lower blood sugar and cholesterol levels.
Who this helps: This benefits desk workers and employers looking to improve health and productivity in the workplace.
Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth.
2024
Scientific reports
Balboni A, D'Angelo C, Collura N, Brusco S, Di Berardino C +9 more
Plain English This study focused on a specific part of glioblastoma, a common and deadly brain cancer, specifically the cancer stem cells (CSCs) that are hard to treat with standard therapies. The researchers discovered that a protein called ASIC3 is found in high levels in these cancer stem cells but is rarely present in healthy brain tissue. By activating ASIC3, they found that it significantly harmed the cancer stem cells without damaging normal neurons, suggesting this could be an effective new treatment strategy for glioblastoma.
Who this helps: This benefits patients with glioblastoma by offering a potential new treatment option.
Toward the Definition of a Repertoire of Technical Professional Specialist Competencies for Operating Room Nurses: An Ethnographic Study.
2024
Healthcare (Basel, Switzerland)
Reato F, Bresil A, D'Angelo C, Gorli M, Ivziku D +2 more
Plain English This study examined the specific skills and competencies needed for operating room nurses, finding that they require a comprehensive set of 17 specialized competencies across six key areas of nursing. These competencies include 19 learning outcomes, 152 tasks, 222 knowledge elements, and 218 skills that go beyond basic training and help ensure high-quality patient care. Recognizing these competencies is important as it helps validate and certify the qualifications of nurses, which ultimately benefits the healthcare system and patient safety.
Who this helps: This helps operating room nurses and healthcare institutions by clarifying essential skills and standards.
Pentadecanoic Acid-Releasing PDMS: Towards a New Material to PreventBiofilm Formation.
2024
International journal of molecular sciences
D'Angelo C, Faggiano S, Imbimbo P, Viale E, Casillo A +7 more
Plain English This study looked at a new material designed to prevent harmful bacteria from forming on medical devices, like catheters and heart valves. Researchers found that a coating of pentadecanoic acid (PDA) on a type of silicone, called PDMS, could effectively release enough PDA to stop bacteria from sticking, releasing between 0.8 to 1.5 micromolar of the acid over 21 days with no harmful effects on human cells. This is important because it could lead to safer medical devices that minimize the risk of serious infections.
Who this helps: This helps patients using medical devices, particularly those at risk of infections.
The experience of Italian student athletes enrolled in a dual career university program: the challenges of employability.
2024
Frontiers in sports and active living
Belluzzi M, Ferraboli A, Gozzoli C, D'Angelo C
Plain English This study looked at how Italian student-athletes balance their sports careers with their education and how this affects their job prospects after graduation. Researchers interviewed 21 student-athletes in a special program designed for them, finding that their unique experiences shape their employability in ways similar to regular university students, but with some important differences. The findings highlight the need for better support and resources for these athletes, especially as they transition from sports to the workforce.
Who this helps: This helps student-athletes and the universities that support them.
Orienteering promoting community and nature connectedness in Italian VET students. An ethnographic Study of a nature-based intervention.
2024
Journal of prevention & intervention in the community
Ferrari V, Marzana D, D'Angelo C
Plain English This research looked at how orienteering activities in urban parks affected first-year vocational students in Italy. The study involved 53 students and found that orienteering improved teamwork, reduced conflicts, and helped students learn navigation skills, while also strengthening their connection to nature and the community. These findings highlight the importance of incorporating outdoor activities in education to boost students' well-being and social ties.
Who this helps: This helps students in vocational education by enhancing their social skills and connection to their environment.